ArticlemedRxiv : the preprint server for health sciences2025
Mapping Neurochemical Signatures onto Brain Structure for Neurotransmitter-Informed Discrimination of Schizophrenia Patients from Healthy Controls.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Background: Schizophrenia (SCZ) is associated with widespread gray matter volume (GMV) reductions, yet the underlying mechanisms driving these alterations remain unclear. This study investigates whether SCZ-related GMV changes co-localize with normative neurotransmitter (NT) density maps derived from healthy individuals. We further examine the diagnostic utility and transdiagnostic relevance of these NT-informed structural patterns within a machine learning (ML) framework. Methods: Structural imaging from 445 SCZ patients and 414 matched healthy controls (HC) were used to train two ML models: (1) an NT-informed model based on spatial cortical and subcortical correlations between GMV and 25 normative NT maps, and (2) an 'NT-unaware' control model using 50 principal components of GMV. Both models were tested for transdiagnostic generalizability in major depression (MDD), bipolar disorder (BD), borderline personality disorder (BPD), and attention-deficit/hyperactivity disorder (ADHD) to determine whether NT-informed and NT-uninformed morphometric patterns reflect psychosis-specific mechanisms. Associations with accelerated brain aging, clinical symptoms, and psychotropic medication exposure were evaluated. Individual feature importance profiles from the NT model were used for clustering to identify potential neurochemical subtypes of SCZ. Results: The NT model had a higher sensitivity, but a lower specificity compared to the control model in distinguishing SCZ from HC (sensitivity Conclusions: Spatial correlations with normative NT distributions provide biologically interpretable insights into SCZ-related GMV alterations, particularly within subcortical systems. The NT-informed model identifies mechanistically distinct subtypes potentially relevant for future NT-based stratification of SCZ. These findings support the future integration of molecular and structural imaging to uncover system-specific vulnerabilities in psychosis and guide more personalized approaches to diagnosis and treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.